Sagimet Biosciences - Series A (SGMT)'s 30-day implied volatility (IV30) was 85.7% at the close on November 10, 2026, down from 88.1% the day before, against a 52-week range of 68.5% to 112.0%. Its 20-day historical volatility was 89.6%.
Data as of November 10, 2026.